Eagle Pharmaceuticals EGRX reported its Q3 earnings results on Monday, November 7, 2022 at 06:50 AM.
Here's what investors need to know about the announcement.
Eagle Pharmaceuticals beat estimated earnings by 23.08%, reporting an EPS of $1.12 versus an estimate of $0.91.
Revenue was up $26.05 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $1.8 which was followed by a 5.05% drop in the share price the next day.
Here's a look at Eagle Pharmaceuticals's past performance:
|Quarter||Q2 2022||Q1 2022||Q4 2021||Q3 2021|
To track all earnings releases for Eagle Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.